The Janus face of cyclooxygenase-2 in ischemic stroke: shifting toward downstream targets

Stroke. 2005 Feb;36(2):182-5. doi: 10.1161/01.STR.0000153797.33611.d8. Epub 2005 Jan 6.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Arachidonic Acid / metabolism
  • Brain / drug effects
  • Brain / pathology
  • Brain Ischemia / pathology
  • Cyclooxygenase 2 / chemistry
  • Cyclooxygenase 2 / metabolism*
  • Cyclooxygenase 2 / physiology*
  • Cyclooxygenase Inhibitors / adverse effects*
  • Cyclooxygenase Inhibitors / pharmacology*
  • Humans
  • Ischemia / pathology*
  • Models, Biological
  • Prostaglandins / metabolism
  • Stroke / metabolism
  • Stroke / pathology*

Substances

  • Cyclooxygenase Inhibitors
  • Prostaglandins
  • Arachidonic Acid
  • Cyclooxygenase 2